Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications.
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Features of Human CD3+CD20+ T Cells.
Quantitative analysis of hindlimbs locomotion kinematics in spinalized rats treated with Tamoxifen plus treadmill exercise.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Sedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.
Costs and quality of life in multiple sclerosis patients with spasticity.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Hunting for autoantibodies in multiple sclerosis.
Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
Clinical characteristics of intermediate uveitis in adult Turkish patients.
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Pages
« first
‹ previous
…
580
581
582
583
584
585
586
587
588
…
next ›
last »